HCA Healthcare, Inc. 8-K

What Happened
HCA Healthcare, Inc. filed a Form 8-K on July 29, 2026, disclosing that a direct, wholly owned subsidiary of HCA (the “Issuer”) increased the maximum aggregate amount of its unsecured commercial paper program from $4.0 billion to $8.0 billion. The short-term notes issued under the program are unconditionally guaranteed by HCA Healthcare, Inc. Other terms of the program remain as previously disclosed in the Parent Guarantor’s Form 8-K filed June 10, 2025.

Key Details

• Increase in commercial paper capacity: from $4.0 billion to $8.0 billion outstanding at any time.
• Security and guarantee: Notes are unsecured and are unconditionally guaranteed by HCA Healthcare, Inc.
• Registration status: The Notes and the related guarantee have not been and will not be registered under the U.S. Securities Act or state securities laws; they cannot be offered or sold in the U.S. without registration or an applicable exemption.
• Reference: Other program terms remain as described in HCA’s 8-K filed June 10, 2025.

Why It Matters
Raising the commercial paper program limit doubles HCA’s short-term borrowing capacity, giving the company more flexibility to manage liquidity and fund operations or working capital needs through short-term debt. Because the notes are unsecured but guaranteed by the parent, they carry the credit backing of HCA Healthcare, Inc.; however, they are short‑term instruments and are not registered for general public resale in the U.S. Investors should view this as a funding and liquidity measure rather than a change to operational performance metrics disclosed elsewhere.